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Measles virus V protein is a Cys-rich polypeptide that is dispensable for virus propagation in continuous cell lines, but necessary for efficient
viral replication in animals. Those functions modulating virus propagation in vivo are not understood completely, although V protein is known to
interfere with the host interferon response and control of viral gene expression. The ability to modulate gene expression was investigated further
with a minireplicon transient expression system in which V protein was found to repress reporter activity. Two regions of the polypeptide
contributed to this repressive effect including the carboxy-terminus and a region conserved in morbillivirus V proteins located between amino
acids 110–131, whereas domains known to mediate the interaction between V and the nucleocapsid (N) protein were not essential. Accumulation
of encapsidated minigenome in transfected cells was inhibited by V protein suggesting that it acted as a repressor of genome replication thereby
limiting availability of template for reporter gene mRNA transcription.
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Measles virus (MV) is a member of the Paramyxoviridae
family within the morbillivirus genus, and as such is an
enveloped RNA virus that contains a single-stranded, non-
segmented, negative-sense RNA genome. The 16-kb MV
genomic RNA is composed of six gene regions, arranged 3′-
N-P-M-F-H-L-5′ (Griffin, 2001), encoding nine known poly-
peptides. The viral genome, whether packaged in mature virions
or functioning as a transcription/replication template in infected
cells, is part of a ribonucleoprotein (RNP) complex. The RNP
complex is formed from genomic RNA encapsidated by
nucleocapsid (N) protein, and noncovalently associated viral
RNA-dependent RNA polymerase composed of the large (L)
catalytic subunit and multiple copies of the phosphoprotein (P).
In addition to the polypeptides found in the RNP, MVencodes 3
other structural proteins including the matrix (M) protein that
lines the inner surface of the viral particle, and the fusion (F) and
hemagglutanin (H) membrane glycoproteins. Finally, there are⁎ Corresponding author. Fax: +1 845 602 4941.
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infected cells (V, R, and C).
V, R, and C, as well as P protein, are encoded by the MV P
gene (Griffin, 2001). The capacity of the P gene to encode
multiple distinct polypeptides is a common paramyxovirus
feature (Lamb and Kolakofsky, 2001). Three of the 4 proteins
specified by the MV P gene (P, V, and R) are identical for the
first 230 amino acids, but translation from alternative reading
frames located in the 3′ end of the P message produces
polypeptides that each contain a unique carboxyl-terminus (C-
terminus). The P protein amino acid sequence corresponds to
faithful translation of the P mRNA, whereas the shorter, Cys-
rich V protein C-terminus is encoded by edited mRNAs
(Cattaneo et al., 1989). The truncated R protein C-terminus is
the product of ribosomal frameshifting (Liston and Briedis,
1995). The fourth polypeptide encoded by the P gene, C protein,
is unrelated to P, V, or R because it is translated entirely from a
different open reading frame (orf) that begins at a downstream
translation initiation codon (Bellini et al., 1985).
V protein is one of the more conserved proteins in the
Paramyxoviridae family (Baron et al., 1993; Lamb and
Kolakofsky, 2001; Tidona et al., 1999). It is most notable for
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C-terminus, which impart zinc binding capability and poten-
tially mediate formation of a zinc-finger-like structure (Fuku-
hara et al., 2002; Huang et al., 2000; Liston and Briedis, 1994;
Paterson et al., 1995; Steward et al., 1995). The relatively high
degree of conservation suggests that viral V proteins perform
one or more essential functions, although multiple studies have
demonstrated that they are not required for viral propagation in
continuous cell lines (Baron and Barrett, 2000; Delenda et al.,
1998; Durbin et al., 1999; Kato et al., 1997b; Nagai, 1999;
Schneider et al., 1997). This apparent contradiction was
reconciled by the discovery that V protein-deficient viruses
often were less virulent when tested in animal model systems.
For example, Sendai virus infection can lead to lethal
pneumonia after intranasal inoculation of mice, but recombinant
viruses engineered with a V protein expression defect were
cleared more rapidly from the lung of some mouse strains
(Delenda et al., 1998; Kato et al., 1997a). Similarly, it has been
reported that New Castle Disease virus mutants replicate less
vigorously in embryonated chicken eggs when unable to
express wild-type (wt) V protein (Mebatsion et al., 2001).
Parainfluenza virus type 3 replication also is impaired in rodents
and monkeys if mutations are introduced in the D and V orfs
(Durbin et al., 1999). Recombinant MVs engineered with V
protein expression defects exhibit similar phenotypes as well.
Such MVs reproduce poorly in cotton rat lungs (Tober et al.,
1998), are less destructive to human thymic implants propa-
gated in SCID mice (Valsamakis et al., 1998), and cause less
mortality after infection of CD46 transgenic mice (Patterson et
al., 2000). Taken together, these results support the hypothesis
that V protein plays an important role in determining the relative
virulence of MV and several other paramyxoviruses.
The relationship between virulence and V protein was
established by studies like those mentioned above, but the V
protein functions responsible for this association remain
undefined. V proteins encoded by simian virus 5 (SV5),
mumps virus, and parainfluenza virus type 2 have received
considerable attention since they have been shown to interfere
with interferon signaling by targeting cellular STAT proteins for
rapid degradation (reviewed in Goodbourn et al., 2000; Gotoh et
al., 2002; Hengel et al., 2005). MV V protein is known to
interact with cellular polypeptides (Lin et al., 1998; Liston et al.,
1995), some of which may be involved in host immune system
evasion, and in fact, it has been recently shown that MV Valso
perturbs STAT signaling (Palosaari et al., 2003; Takeuchi et al.,
2003; Yokota et al., 2003). In addition to their effect on
interferon signaling, V proteins also might modulate virulence
by controlling viral replication. Sendai virus V protein has been
shown to inhibit replication of defective interfering particles
(Curran et al., 1991; Horikami et al., 1996), and it also has been
noted that several different V protein-deficient recombinant
paramyxoviruses produce elevated levels of genomic RNA,
mRNA, and viral proteins during infection (Baron and Barrett,
2000; Kato et al., 1997a; Tober et al., 1998). The mechanism by
which V protein controls gene expression and replication is
unknown, but it is possible that interaction with N protein or the
catalytic subunit (L) of the viral polymerase may be important(Curran et al., 1991; Horikami et al., 1996; Svenda et al., 2002;
Sweetman et al., 2001).
The potential association between MV virulence and the
control of viral gene expression by V protein led us to examine
this modulatory activity in more detail. We exploited a transient
expression assay system in which it was possible to observe V
protein-mediated repression of minireplicon-encoded reporter
gene expression. This transient assay system made it possible to
examine the function of multiple V protein mutants leading to
identification of two regions of the polypeptide that mediate its
repressive effect. Consistent with studies employing Sendai
virus model systems, the inhibitory effect exerted by MV V
protein appeared to result from repressed levels of minigenome
replication, but surprisingly, the repressive effect was not
mediated by a V–N protein–protein interaction.
Results
Repression of minireplicon-encoded gene expression by V
protein
Previous findings (Baron and Barrett, 2000; Curran et al.,
1991; Horikami et al., 1996; Kato et al., 1997a; Tober et al.,
1998) have shown that viral V proteins control gene expression
and replication, although the mechanism by which this
modulatory effect is exerted is not well understood. To establish
a system that would facilitate further analysis of this V protein
function, we first examined whether MV V could control
expression from a minireplicon in transient expression assays.
Plasmids prepared to conduct this analysis included a
minireplicon encoding the CAT reporter gene, and plasmids
encoding the Edmonston wt (Parks et al., 2001b) N, P, L, and V
proteins. To prevent potential ambiguity caused by C protein
expression from within the overlapping orf (Bellini et al., 1985)
found in the P and V expression vectors, both plasmids were
modified to preclude translation from the downstream C protein
initiation codon.
A titration experiment was performed to determine whether
V protein influenced minireplicon-encoded CAT expression.
HEp-2 cells cultured in 6-well plates were cotransfected with
increasing amounts of pMV-V (Fig. 1A, lanes 1–7) and
constant amounts of minireplicon DNA plus plasmids encoding
N, P, and L proteins. Cells were infected with MVA/T7 or
MVAGKT7 to supply intracellular T7 RNA polymerase needed
to transcribe mRNAs from the protein expression plasmids and
synthesize a negative-sense minireplicon RNA to serve as
template for nucleocapsid assembly and subsequent minige-
nome replication and CAT mRNA synthesis. CAT assay results
were quantified (Fig. 1A, lanes 1–7) and levels of reporter
expression were calculated relative to CAT activity observed in
the absence of V protein (Fig 1A, lane 1). A control transfection
illustrated that CAT expression was dependent upon the
presence of MV trans-acting proteins since virtually no reporter
activity was observed when the expression vector encoding the
L polymerase subunit was omitted (lane 2). Comparison of CAT
activity in the positive control (lane 1) with the results in lanes
3–7 revealed that increasing amounts of cotransfected pMV-V
Fig. 1. Repression of minireplicon-encoded gene expression by V protein. In
part A, increasing quantities of plasmid expressing MV (lanes 1–7) or HA-
tagged CDV (lanes 9–14) V protein was cotransfected with plasmids encoding
the MV or CDV trans-acting polypeptides (N, P, L) needed to drive
minireplicon-encoded reporter expression. The total mass of transfected DNA
was held constant by including the appropriate amount of T7 expression vector
lacking an insert. Relative CAT activity was calculated based on 100% activity
in lane 1 for MVor lane 10 for CDV. In part B, increasing quantities of plasmid
encoding an HA epitope-tagged MV V protein (Fig. 3; pMV-haV) were
cotransfected with plasmids encoding VSV N, P, L, and the VSV minireplicon.
VSV minireplicon-encoded CAT activity is expressed relative to the amount
observed in lane 2 in which pMV-haV was excluded from the transfection.
Repression of gene expression from MV-CAT by haV protein was confirmed in
parallel (lanes 6–7) as described in part A.
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This dose-dependent repressive effect was observed consistent-
ly in subsequent experiments, although the magnitude of the
negative response varied from experiment to experiment most
likely reflecting the variability inherent in transient expression
assays.
Canine distemper virus (CDV) V protein was tested as well
to determine whether the repressive activity was conserved by
additional morbilliviruses. In the experiment shown in Fig. 1A
(lanes 9–14), expression vectors encoding CDV N, P, L (Parks
et al., 2002), and V protein were substituted for their MV
counterparts. The MV minireplicon was used in this experi-
ment, rather then the equivalent CDV reporter construct, to
avoid the high background levels of CAT activity produced by
transfection of the CDV minireplicon plasmid DNA (Gassen et
al., 2000; Parks et al., 2002). Inclusion of CDV V resulted in
repression of CAT activity (lanes 11–14) demonstrating that
both MV and CDV V proteins possess repressive function.It was evident that MV V protein was a relatively potent
inhibitor of minireplicon-encoded gene expression, but it
remained to be determined whether this repressive effect was
specific. Perhaps, high levels of V protein simply induced a
global reduction in gene expression in transfected cells, or
inhibited production of transcripts by T7 RNA polymerase. To
rule out these less specific modes of action, we examined
whether MV V protein repressed CAT expression from a
heterologous rhabdovirus minireplicon. In this experiment, cells
were transfected with plasmids encoding vesicular stomatitis
virus (VSV) N, P, and L proteins, and a VSV-CAT minireplicon.
Increasing amounts of cotransfected pMV-V did not modulate
reproducibly VSV minireplicon-encoded gene expression (Fig.
1B, lanes 3–5) as demonstrated in this experiment by relative
CAT values that were not significantly different from those
observed in the absence of V protein (lane 2). In contrast,
inclusion of pMV-V inhibited expression from the MV
minireplicon (lanes 6–10) in a dose-dependent manner as
predicted by the results from earlier experiments. These results
indicate that selective suppression by MV V protein is
observable in the minireplicon assay.
Repression mediated by mutant V proteins
To identify V protein domains that contribute to its
repressive function, a series of plasmids were created that
express modified polypeptides. Regions of V protein targeted
for mutagenesis were selected by a variety of methods. Some
were chosen by assuming that important functional motifs were
located in regions of V protein that contained notable sequence
conservation among morbilliviruses (Fig. 2). Additional regions
of interest were chosen based on computer-aided identification
(see Materials and methods) of putative functional motifs, and
review of earlier studies that identified functional domains in V
or the overlapping sequences of P protein (Figs. 2 and 3A).
The alignment shown in Fig. 2 highlights seven regions of
MV V that share sequence similarity with rinderpest virus
(RPV), CDV, peste-des-petits ruminants virus (PPRV), phocine
distemper virus (PDV), and dolphin morbillivirus (DMV).
Some of these conserved regions (CR) contain functional motifs
identified in earlier studies, for example, the extreme amino
terminus (CR1) mediates interaction between P and N proteins
(Harty and Palese, 1995) and presumably serves a similar
function in V protein. V–N complex formation may be
influenced by sequences located between amino acids 204
and 230 (Huber et al., 1991; Tober et al., 1998) that overlap with
CR4 as well. The alignment also reemphasized the fact that the
C-terminus contains 7 precisely arranged Cys residues (Baron et
al., 1993; Fukuhara et al., 2002; Lamb and Kolakofsky, 2001;
Tidona et al., 1999). Both CR5 and CR6 are contained within
the C-terminal Cys-rich domain.
Other potentially interesting sequence features evident in the
alignment included a short but completely conserved region rich
in basic amino acids that may be available to form electrostatic
interactions (amino acids 228–235 IKKGHRRE). This basic
sequence includes the highly conserved HRRE motif (Tidona et
al., 1999). Another region of potential interest in MV V
Fig. 2. Comparison of morbillivirus V protein amino acid sequences. The MV V protein amino acid sequence (accession number: AF266288) was compared to RPV
(Z30697), CDV (AF014954), PPRV (AJ298897), PDV (D10371), and DMV (Z47758). Identity to MV V protein is shaded in blue. Seven regions of similarity are
indicated with a solid red bar above the amino acid sequence, and are designated as Conserved Regions 1 through 7 (CR1 through CR7). Additional noteworthy
sequence features also are featured and described in the text. The region common to V and P protein extends from MVamino acids 1–231 and the unique V protein
sequences (bold blue amino acid letters) extend from 231–299.
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of leucine-zippers (Alber, 1992; Baxevanis and Vinson, 1993).
Finally, amino acid position 225 was noteworthy because a
substitution occurs at this position in Edmonston vaccine strains
(wt E to vaccine G; Parks et al., 2001b).
Before preparing vectors encoding mutant V proteins, the
pMV-V expression plasmid was modified to include an N-
terminal HA epitope tag (Kolodziej and Young, 1991). This
facilitated Western blot detection of tagged V proteins fromtransfected cell lysates allowing for comparison of the relative
steady-state levels of modified V proteins. The tagged wt V
protein was found to fully retain its ability to repress CAT
expression (data not shown, and Fig. 4).
The first series of mutations introduced into haV were
directed at some of the sequence motifs illustrated in Fig. 2. One
of the mutations created a truncated polypeptide that lacked the
unique V protein C-terminus (Fig. 3A, haV-1). Plasmid haV-2
contained the vaccine virus Vamino acid substitution (E to G) at
Fig. 3. Expression vectors encoding mutant V proteins. Amino acid sequence motifs and functional domains (see Fig. 2) are displayed along the V protein map in part
A. Part B illustrates the structure of wt (haV) and mutant V protein expression vectors (haV-1 through haV-11, and haV1+5). The vectors were designed with the
coding sequence for the influenza virus HA epitope tag (Kolodziej and Young, 1991) inserted in place of the V protein initiator methionine codon. Amino acid
substitutions are indicated with a black dot along with the corresponding amino acid substitution. Deletion or truncation mutants are drawn as an interrupted V protein
map.
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contained amino acid substitutions in the CRs. Amino acid
substitutions were used to selectively modify the CRs
presumably without grossly altering overall protein structure.
A strategy suggested by the charged-to-alanine approach (BassFig. 4. Repression of MVminireplicon-encoded reporter gene expression by mutant V
effect produced by mutant V proteins haV-1 through haV-8. The amount of transfecte
shown below the assay results. Western blotting (part B) was performed with anti-HA
Western analysis was performed with cells transfected identically to those used for
contained a negative control derived from cells transfected with a vector that expreset al., 1991; Diamond and Kirkegaard, 1994; Gibbs and Zoller,
1991) was used where two consecutive codons for charged or
polar amino acids were converted to Ala.
A representative transient expression assay performed with
pMV-haV vectors 1–8 is shown in Fig. 4A in which 200 or 400proteins. An example CATassay is shown (part A) demonstrating the repressive
d V protein vector (200 or 400 ng) and the relative CAT activities (see Fig. 1) are
antibody to monitor V protein expression in transient expression experiments.
CAT assays in which 400 ng of V protein expression vector was used. Lane 1
sed wt V protein lacking a tag.
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pMV-V (lane 4) or pMV-haV encoding the tagged derivative
(lane 6) repressed more than 90% of the CAT activity observed
in the positive control (lane 2). The majority of the mutant V
proteins tested in this experiment (lanes 10, 12, 14, 18, 20, 22),
as well as repeat experiments, also exhibited potent repression
activity indicating that the mutations had little effect. In
contrast, repression mediated by vectors haV-1 (lane 8) and
haV-5 (lane16) was less effective indicating that it would be
informative to study these mutants in more detail.
To determine whether ineffective repression by haV-1 or
haV-5 simply correlated with poor protein expression, a
Western blot was performed using anti-HA antibody (Fig.
4B). All mutant V proteins were detected readily (lanes 2–10),
and the Western blot signal was judged to be specific since
extracts prepared from cells transfected with vector encoding V
protein lacking the HA tag did not generate a band (lane 1). The
truncated polypeptide in lane 3 (haV-1, Fig. 4B) exhibited
noticeably altered mobility, as did some of the other mutant
proteins, which contained substitutions that replaced charged or
polar amino acid residues (Fig. 4B, lanes 4–10). At times, the
abundance of haV-1 or haV-5 was reduced, but in this and
subsequent experiments, Western analysis did not reveal a
consistent trend that would suggest that any of the mutant
polypeptides were substantially less stable.
To further characterize the phenotype of haV-1 and haV-5, a
titration experiment was performed to determine whether higher
levels of protein expression could offset the repression defect.
The results (Fig. 5A) indicated that expression of greater
quantities of either mutant protein partially restored repression
activity. As seen in Fig. 5A, the positive control haV plasmid
produced a near linear repression response (lanes 4–7), whereas
the effect induced by either haV-1 (lanes 8–12) or haV-5 (lanes
13–17) required transfection of substantially greater quantities
of expression vector before repressive activity was evident. This
finding suggested that two separate domains contributed
additively to the repressive activity of V protein. To examine
this possibility in more detail, a mutant expression vector was
constructed that contained both the haV-1 and haV-5 mutations.
This double mutant (haV1+5, Fig. 3B) failed to significantlyFig. 5. Degree of repression defect exhibited by haV-1 and haV-5. The repressive activ
ha-V (part A). The experiment was performed essentially as described in Fig. 1 except
performed with a fraction of the lysates used to evaluate CAT expression.repress reporter gene expression even at the highest concentra-
tions tested (Fig. 5A). Western blot analysis verified that this
result did not correlate with differences in V protein expression
or stability (Fig. 5B).
Role of V–N complex formation in repression
Previous studies have shown that Sendai virus V protein
inhibits replication of defective-interfering (DI) particles
(Curran et al., 1991, 1995; Horikami et al., 1996). These results
led to the proposal of an elegant model in which V protein
exerted its repressive effect through direct interaction with N
protein (Horikami et al., 1996). It was postulated that formation
of a V–N protein–protein complex sequestered sufficient N
protein to limit encapsidation and replication. Although this
seemed to be the most attractive model to apply to our findings,
it did not fit well with the data shown in Fig. 4; those mutations
(haV-1 and haV-5) that diminished repression function were
within regions not expected to mediate V–N (or P–N) complex
formation (Figs. 2 and 3A). Conversely, amino acid substitu-
tions within domains thought to mediate V–N (or P-N)
interaction did not appreciably affect repression (Fig. 4, mutants
haV-4, -7, and-8), although it was possible that these mutations
did not sufficiently destabilize the V–N complex to impact
repression. This interpretation of our results indicated that
further analysis was required to determine whether V–N
complex formation played a significant role in repression
mediated by MV V.
The V–N protein–protein interaction was examined by
taking advantage of the N-terminal HA epitope tag encoded by
the V protein expression vectors. Cytoplasmic extracts prepared
from transfected cells were subjected to immunoprecipitation
(IP) with anti-HA affinity resin to capture tagged proteins (Fig.
6A), which were then analyzed by Western blotting to detect
HA-tagged V protein and coimmunoprecipitated N protein. A
Western blot reacted with anti-HA antibody (top of Fig. 6A)
revealed that proteins haV-1 through haV-8 were effectively
captured by the anti-HA resin. As expected, extracts prepared
from cells expressing V protein lacking a tag (lane 1) did not
produce a signal. Examination of immunoprecipitatedity of haV-1, haV-5, and a double-mutant (haV1+5; Fig. 3B) was compared to wt
that the titration was conducted over a broader range.Western blots (part B) were
Fig. 6. V–N complex formation is not essential for repression activity. In part A, cells transfected with plasmids encoding wt and mutant V proteins (haV-1 through 8)
as well as minireplicon and N, P, and L proteins were used to prepare cytoplasmic extracts from which protein complexes were immunoprecipitated with anti-HA
antibody. Western blotting was performed with anti-HA monoclonal (top) to detect HA-tagged V protein or anti-N (bottom) monoclonal antibody to examine the
composition of the complexes. A negative control was prepared from cells transfected with a vector expressing V protein lacking the HA-tag (lane 1). In part B,
deletion mutants (haV-9 through 11; Fig. 3) were tested for their ability to repress CAT expression (part A) as described in Fig. 4. Lanes 2, 7, 12, and 17 were positive
control transfections performed without plasmid expressing V protein. A portion of the extract was reserved for Western Blot analysis (part B, bottom) as described in
Fig. 5. In part C, protein complexes formed with deletion mutant V proteins were analyzed as described in part A.
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associated with all of the tagged V proteins (Fig. 6B, lanes 2–
10), clearly illustrating that the HA-tag did not block association
between the two polypeptides, and that proteins haV-1 through
haV-8 retained the ability to form a stable complex with N.
Consequently, it appeared that loss of repression function by
haV-1 or haV-5 did not directly correlate with the inability to
complex with N protein.
At times, it appeared that proteins haV-7 and haV-8, which
contained amino acid substitutions within the first 15 amino
acids of V protein (Fig. 3B), coprecipitated marginally less N
protein (Fig. 6A). This suggested that Ala substitutions at
residues 14 and 15 (haV-7; Fig. 3B) or 3 and 4 (haV-8; Fig.
3B) might produce a less stable interaction between the two
proteins consistent with the results of Harty and Palese (1995)
who showed that MV P protein, and likely V protein,
contained an N protein-binding domain in the extreme N-
terminus. Although these mutations might destabilize the V–
N complex, proteins haV-7 and haV-8 were effective at
repressing minireplicon-encoded gene expression (Fig. 4)
perhaps providing additional support for the conclusion thatV–N complex formation and minireplicon repression were
unrelated activities.
To solidify the hypothesis that repression by V protein did
not require interaction with N protein, three additional vectors
were designed to express polypeptides in which domains
thought to play a role in the V–N protein–protein interaction
were removed (haV-9 through haV-11; Fig. 3B). The first 20
amino acid codons were removed from plasmid haV-9 including
all of the coding sequence for CR1 and the N protein-binding
domain identified by Harty and Palese (1995). The second
plasmid (haV-10) lacked the coding sequence for amino acids
208–230, which includes a region that affects the intracellular
localization of the V–N complex (Huber et al., 1991; Tober et
al., 1998). The third mutant (haV-11) contained both deletions.
Vectors haV-9, 10, and 11 were found to repress CAT
expression as effectively as wt haV protein (top of Fig. 6B),
and Western blot analysis indicated that the deletion
mutations did not diminish protein expression or stability
significantly (bottom Fig. 6B). When immunoprecipitation
analysis was performed (Fig. 6C), anti-HA antibody effec-
tively captured all three mutant V proteins (lanes 2–5).
Fig. 7. Reduction in minireplicon genomic RNA and CAT mRNA levels induced by V protein. The bicistronic minireplicon (part A) is a derivative of pMV-CAT
created by inserting the MV N/P gene end-gene start (GE-GS) signal and luciferase open reading frame 3′ of the CAT gene. The negative-sense oligonucleotide probe
used for hybridization is shown below the minireplicon map along with RNA species that can be transcribed from minigenome. Northern blot analysis (part B) was
performed with total cytoplasmic RNA (lanes 1–5) or RNA prepared from nuclease-treated cytoplasmic lysates (lanes 6–10). Ten micrograms of total cytoplasmic
RNA (lanes 1–5) was compared to the entire nuclease-resistant fraction (lanes 6–10) recovered from a 60 mM dish. Thus, the relative amount of RNA examined after
nuclease treatment was equivalent to about 5-fold more RNA than loaded in lanes 1–5. Lanes 1 and 6 contain the negative-control RNAs that were prepared from cells
transfected without addition of the L expression vector. The positive-control RNAs (lanes 2 and 7) were isolated from cells transfected without inclusion of plasmid
expressing V protein. Migration of RNA markers (kb) is indicated adjacent to the blot. A picture of the ethidium bromide-stained gel used to prepare the blot is
included at the bottom of the figure.
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from two complexes (lanes 8 and 10), and in both cases, the
V proteins lacked their 20 N-terminal amino acids (haV-9 and
haV-11). In contrast, deletion of amino acids 208–230 had
little effect on coprecipitation of N protein (haV-10, lane 9).
Taken together, these results confirmed that the first 20 amino
acids contained the region primarily responsible for V–N
complex formation and that this domain was not required for
V protein-mediated repression.
V protein reduces CAT mRNA and minigenome levels
Finding that two mutant V proteins retained repressive
function despite the fact that V–N complex formation was
abolished demonstrated that MV V protein did not conform to
the accepted Sendai virus repression model. Thus, it was
relevant to question whether MV V protein repressed genome
replication like Sendai virus V or possibly acted through an
alternative mechanism. To address this question, Northern blots
were performed to determine what affect MV V had on reportergene mRNA and minigenome levels in transfected cells. For
this experiment, a bicistronic minireplicon (Fig. 7A) was used to
distinguish CAT mRNA from positive-sense genomic RNA.
This minigenome configuration still encodes a monocistronic
CAT message, but directs replication of a larger positive-sense
bicistronic genomic RNA. Hybridization of total RNA with an
oligonucleotide probe (Fig. 7A) specific for the 5′ end of the
CATcoding region and adjacent noncoding sequences produced
two bands (Fig. 7B, lanes 1–5). The size of the larger 2.6-kb
band was consistent with positive-sense minigenome RNA
replication intermediate and CAT-Luciferase read-through
mRNA. The smaller 0.75-kb band was the correct size for
CAT message. As the CAT assays predicted, increased
expression of V protein resulted in decreased levels of the
0.75-kb CAT mRNA, and also resulted in declining amounts of
the larger 2.6-kb RNA species (Fig. 7B, lanes 2–5). Levels of
28 and 18S rRNAs, visualized by ethidium bromide staining
(Fig. 7B, bottom), indicated that the disappearance of CAT
mRNA and the 2.6-kb RNA species was not due to an artifact
caused by RNA degradation.
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diminished by V protein and suggested that genome synthesis
was affected as well, but it remained to be determined
whether the decline in the 2.6-kb species was due primarily to
reduced genome replication or repressed synthesis of a CAT-
Luciferase bicistronic mRNA. To clarify this point, the
cytoplasmic fraction isolated from transfected cells was
subjected to digestion with RNase I prior to RNA purification
to degrade RNAs that were not protected by a nucleocapsid.
This treatment was judged to be effective as the 0.75-kb CAT
mRNA was completely eliminated by nuclease digestion as
was the abundant 28s and 18s ribosomal RNAs (Fig. 7B,
lanes 6–10). On the other hand, the probe hybridized with a
significant amount of the 2.6-kb RNA (Fig. 7B, lanes 7 and
8) indicating that it was nuclease-resistant and most likely a
positive-sense genomic RNA. It was evident as well that this
nuclease-resistant RNA decreased in response to increased
levels of V protein demonstrating that V repressed positive-
sense genomic RNA synthesis. This result further implied that
diminished replication of the minigenome likely limited the
availability of transcription template ultimately producing a
decline in mRNA levels and CAT activity.
Discussion
V proteins from MV and CDV were found to repress
minireplicon-encoded reporter gene expression. This repressive
effect was determined to be selective when it was shown that
MV V protein was unable to modulate expression from a VSV
minireplicon. Analysis of RNA accumulation in transfected
cells revealed that the molecular basis for repression by MV V
protein corresponded with reductions in CAT mRNA and
encapsidated minigenomic RNA levels. The inhibition of
minigenomic RNA accumulation induced by MV V protein
(Fig. 7B), which greatly reduced the available template for
mRNA synthesis, appeared to be more than sufficient to account
for the observed reductions in CAT mRNA (Fig. 7B) and
protein (Fig. 1A) in transfected cells. This interpretation of our
results led to the conclusion that V protein-mediated repression
occurred principally at the level of genome replication in
agreement with earlier studies performed with Sendai virus V
(Curran et al., 1991; Horikami et al., 1996), although at this time
we cannot rule out the possibility that MV V protein generally
repressed all MV-specific RNA synthesis. Recently, Lin et al.
(2005) have used a similar transient expression approach to
study the V protein encoded by the Rubulavirus SV5 and
concluded that it acts as a general repressor of all viral-specific
RNA synthesis. Taken together, perhaps these studies indicate
that paramyxovirus V proteins are negative modulatory factors,
but that the mechanisms by which different V proteins act may
differ.
To account for the negative modulatory activity of Sendai V,
a logical and well-accepted model was proposed in which
repression was linked to V–N complex formation (Horikami et
al., 1996). The V–N complex is thought to sequester N protein
limiting its availability to encapsidate genomes and promote
subsequent rounds of replication. Although this is an appealingmodel, our results indicate that MV V protein modulates
replication through a different pathway. In fact, mutant MV V
proteins were produced that were defective for V–N complex
formation but retained the ability to efficiently repress
minireplicon-encoded CAT expression. As mentioned above,
perhaps Sendai virus and MV V both repress replication but
employ different mechanisms. This proposal gains some merit
from the fact that the two V proteins are notably different. For
example, the extreme N-terminus of MV V protein is required
for V–N complex formation (Fig. 6C), whereas this region of
Sendai virus V protein may be dispensable for binding to N
protein (Horikami et al., 1996). Additionally, the C-terminus of
Sendai virus V protein is not essential for repression (Curran et
al., 1991; Horikami et al., 1996) whereas this region is
necessary for MV V protein to exhibit full repression activity
(Figs. 4 and 5). Also notable, there is relatively little amino acid
sequence identity between the two polypeptides outside of the
conserved Cys residues and the HRRE motif in the C-terminus
(Tidona et al., 1999).
While investigating the potential role of V–N complex
formation in repression, the interaction between the two MV
proteins was examined in some detail. Previous reports
suggested that two regions of MV V protein participated in
the V–N protein–protein interaction. Two-hybrid analysis
indicated that the first 10 amino acids of MV P protein
promoted complex formation with N protein (Harty and
Palese, 1995), and likely performed the same function in V
protein. Our results confirmed this observation; coimmuno-
precipitation studies revealed that deletion of the N-terminal 20
amino acids from V protein abolished detectable V–N
complex formation (Fig. 6C). The second region of MV V
protein previously implicated in V–N complex formation was
localized between amino acids 204 and 230 (Huber et al.,
1991; Tober et al., 1998). In this earlier study, coexpression of
V and N protein resulted in redistribution of N protein in
transfected cells; N protein expressed by itself localized
primarily to the nucleus, whereas the V–N complex was
retained in the cytoplasm. Our results indicate that this region
of V protein did not physically interact with N protein (Fig.
6C), which may suggest that this domain is not directly
involved in formation of the V–N complex but acts instead as
a cellular localization signal that helps maintain V–N
complexes in the cytoplasm.
The repressive action of MV V protein clearly was evident in
the minireplicon assay, but it remains to be determined how this
function affects gene expression and replication during viral
infection. Although our studies have not yet addressed this
question, there is evidence suggesting that MVV protein plays a
similar role in the infected cell. Recombinant morbilliviruses,
MV and RPV, that are defective for V protein expression
produce elevated levels of genomic RNA, mRNA, and viral
protein (Baron and Barrett, 2000; Kato et al., 1997b; Tober et
al., 1998) suggesting that these engineered strains have been
released from a negative regulatory pathway. Our results can be
used to guide future studies in which the effect of specific V
protein mutations can be selectively examined in the context of
recombinant viruses.
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mechanism that is independent of V–N complex formation,
alternative models will influence further investigation. Since the
Cys-rich C-terminus may contain a zinc-finger-like structure, it
is appealing to propose that this region of V protein might
function as a nucleic acid-binding domain that modulates
replication through a protein–RNA interaction. Recent inves-
tigation has identified an RNA-binding activity within the C-
terminus (Parks et al., 2006) that may play a role in repression.
Materials and methods
Cells and virus
HEp-2, Vero, BHK, and chicken embryo fibroblasts (CEF)
cells were maintained in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum. Two
attenuated vaccinia virus strains that express bacteriophage T7
RNA polymerase were used in minireplicon experiments.
MVA/T7 (Wyatt et al., 1995) and MVAGKT7 (Kovacs et al.,
2003) were propagated and titered in CEF or BHK cells.
Recombinant DNA
Recombinant plasmid DNAs were constructed using
standard cloning techniques (Ausubel et al., 1987), and
sequences were confirmed by cycle-sequencing (Kretz et al.,
1994). Protein expression plasmids used in minireplicon
assays encoding MV N, P, V, and L were cloned from
infected-cell RNA purified by the guanidinium–phenol
extraction method (Chomczynski and Sacchi, 1987). RNA
was purified from Vero cells infected with a low-passage
strain of Edmonston wt MV (Parks et al., 2001b) from which
cDNA was prepared by reverse transcription and PCR
amplification (RT-PCR) with gene-specific primers and an
enzyme mixture contained in the Titan One-Tube RT-PCR Kit
(Roche Molecular Biology). Amplified DNA fragments were
cloned into a vector from which protein expression was
controlled by the phage T7 RNA polymerase promoter and an
IRES element (Moss et al., 1990; Parks et al., 2002; Radecke
et al., 1995). The primer designed to amplify the 5′ end of the
P and V coding regions (cggccatggcagaagagacagg cacgc-
caCgtAaaaaacggac) contained two base changes (capitalized)
that disrupted the downstream C protein orf. These nucleotide
substitutions were silent with respect to the P and V orfs
while they eliminated the C protein initiation codon and
converted the following codon to a stop signal. In addition to
this modification, the V protein expression plasmid was
modified by insertion of a G at the position corresponding to
the mRNA editing site (Cattaneo et al., 1989). An amino-
terminal (N-terminal) epitope-tagged wt V protein expression
clone (pMV-haV) was prepared by inserting the influenza
virus hemagglutinin (HA) epitope coding sequence (Kolodziej
and Young, 1991) in place of the V protein initiation codon.
Modified V protein expression vectors containing mutations
in the protein coding sequence were prepared in the pMV-haV
backbone by oligonucleotide-directed mutagenesis. Regionstargeted for mutagenesis were chosen with the aid of computer
analyses performed with GCG (Pharmacopeia) or MegAlign
(DNASTAR, Inc) software packages (Figs. 2 and 3).
The MV minireplicon (pMV-CAT) reporter construct
contained the noncoding cis-acting sequences found in the
transcriptional control region of the Edmonston wt strain of MV
(Parks et al., 2001a). Plasmid pMV-CAT was prepared from
pMV107-CAT (Sidhu et al., 1995) by performing oligonucle-
otide mutagenesis to convert the pMV107-CAT vaccine virus
transcriptional control region to wt. The bicistronic minirepli-
con (pMV-CAT/Luc; Fig. 7A) was constructed by inserting the
MV N-P gene-end/gene-start (GE-GS) signal and luciferase orf
downstream of the CAT gene in pMV-CAT. Both the luciferase
cDNA and the MV-CAT minireplicon vector DNA were
synthesized by PCR amplification to facilitate insertion of a
synthetic copy of the MV N-P GE/GS between the CAT and
luciferase genes through sequences incorporated into the PCR
primers.
Cloned plasmid DNAs were required for two additional
transient expression systems. The CDV N, P, and L expression
plasmids have been described previously (Parks et al., 2002).
The HA-tagged CDV V protein expression vector was prepared
using methods described above. The VSV N, P, and L coding
sequences were amplified by PCR from a VSV genomic cDNA
clone (Lawson et al., 1995) prior to their insertion into the T7
expression plasmid. The VSV-CAT minigenome plasmid was
prepared by replacing the MV 5′ and 3′ noncoding sequences in
pMV107-CAT (Sidhu et al., 1995) with PCR-amplified
sequences from the VSV genomic clone.
Transient expression analysis
Analysis of transient minireplicon-encoded gene expression
was performed in HEp-2 cells cultured in 6-well plates as
described earlier (Parks et al., 2002). Briefly, transfection mixes
were prepared by combining minireplicon DNA (100–500 ng)
and expression plasmids (400 ng N, 300 ng P, 100 ng L, 25–
1600 ng various V constructs) in 200 μl of serum-free
OptiMEM (Invitrogen) containing 12 μl of Lipofectace or 4–
6 μl of Lipofectamine 2000 (Invitrogen). After incubation for
10–20 min at room temperature, the mixture was combined
with 800 μl of OptiMEM containing sufficient MVA/T7 (Wyatt
et al., 1995) or MVAGKT7 (Kovacs et al., 2003) to infect the
monolayer with approximately 5–10 plaque-forming units per
cell when the mixture subsequently was added to the culture
vessel. The following day, the medium was replaced and the
cells were incubated an additional 24 h at which time they were
harvested for extract preparation and analysis of CAT activity,
which was quantified using a fluorescent chloramphenicol
derivative (Molecular Probes) and a fluorimager (Parks et al.,
2002). Each transfection experiment and corresponding CAT
assay were performed multiple times to ensure reproducibility.
A representative example is shown in the figures.
Western blotting was used to assess protein abundance in
crude cytoplasmic extracts produced from transfected cells
(Ausubel et al., 1987). Cells were lysed using TN buffer (50
mM Tris pH 7.4, 150 mMNaCl) supplemented with 0.2% NP40
117S.E. Witko et al. / Virology 348 (2006) 107–119and protease inhibitor cocktail (Roche Molecular Biology). The
crude cell extracts were centrifuged to remove nuclei before an
equal volume of Laemmli buffer (62.5 mM Tris pH 6.8, 25%
glycerol, 2% SDS, 0.01% bromophenol blue) was added to the
cleared lysate at which time the samples were adjusted to
contain approximately 1.0% β-mercaptoethanol and boiled for
5 min. SDS polyacrylamide gel electrophoresis and electro-
blotting were performed using standard protocols (Ausubel et
al., 1987). HA epitope-tagged V protein was detected with
either mouse monoclonal antibody 12CA5 (Roche Molecular
Biology) or rat monoclonal antibody 3F10 (Roche Molecular
Biology). Detection was performed with a peroxidase-conju-
gated secondary antibody (Sigma) and chemiluminescent
reagents (Roche Molecular Biology, New England Nuclear, or
Pierce).
RNA levels were assessed by Northern blot analysis. HEp-2
cells grown to approximately 75% confluence in 60 mm dishes
were transfected as described above except that all reagents,
plasmid DNAs, and MVA/T7 or MVAGKT7 were scaled up
three-fold to accommodate the larger number of cells in the 60
mm dish. 48 h after the start of transfection, the monolayers
were scraped into PBS containing 1 mM EDTA and the cells
were collected by centrifugation. Total RNAwas prepared from
cell pellets using the guanidinium–phenol–chloroform extrac-
tion method (Chomczynski and Sacchi, 1987) and Trizol LS
reagent (Invitrogen). Encapsidated minireplicon RNA was
prepared from cytoplasmic extracts treated with nuclease.
Briefly, transfected cell pellets were resuspended in 300 μl of
cold lysis buffer (20 mM Tris pH 7.5, 150 mM NaCl, 0.2%
NP40) by repeated gentle pipetting to facilitate disruption of the
cytoplasmic membrane. Nuclei were removed from the crude
lysates by centrifugation, and the cleared supernatants were
transferred to fresh tubes prior to the addition of 10 units of
RNase I (Promega). Nuclease-sensitive RNAwas digested at 30
°C for 2 h before the reaction was terminated by extraction with
0.9 ml of Trizol-LS reagent (Invitrogen).
Purified RNAs were electrophoresed in denaturing agarose
gels containing glyoxal prior to transfer to a nylon membrane
(Ausubel et al., 1987). Samples containing total RNA (10 μg) or
nuclease-resistant RNA (entire sample) were diluted in glyoxal
loading dye (Ambion) and heated at 65 °C for 30 min before
being electrophoresed in 1.3% agarose gels prepared in 1×
glyoxal buffer (Ambion). 4 μg of a biotinylated RNA marker
(Ambion) was run concurrently. Following electrophoresis at
100 V for 1.5 h, the RNA was transferred to a Biodyne B
membrane (Pierce) for 2 to 3 h with a TurboBlotter (Schleicher
and Schuell) following the protocol described by Ingelbrecht et
al. (1998). RNA was UV cross-linked to the nylon membrane
with a Stratalinker 1800 (Stratagene). Positive-strand genomic




GAGGCTCTG GATCCC, Fig. 7A) that was biotinylated with a
psoralen–biotin conjugate (Ambion). The biotinylated probe
was hybridized following standard protocols (Ausubel et al.,
1987) with buffers supplied in the North2South Chemilumi-nescent Nucleic Acid Hybridization and Detection kit (Pierce).
Hybridization was performed overnight at 55 °C in the presence
of 100 μg/ml sheared salmon sperm DNA (Sigma). Subse-
quently, blots were subjected to high-stringency washes
performed at 55 °C. Chemiluminesence detection was executed
with reagents supplied in the North2South kit.
Immunoprecipitation of HA-tagged V protein was performed
using monoclonal antibody 3F10 coupled to agarose beads
(Roche Molecular Biology). Cytoplasmic extracts were pre-
pared from transfected cells by lysis with IP buffer (TN buffer
supplemented with 0.5% NP40, 1.0 mMMgCl2, 0.5 mM ZnCl2,
and 5% glycerol) that included an EDTA-free protease inhibitor
cocktail (Roche Molecular Biology). The extracts were cleared
by centrifugation before antibody resin was added and the
extract was allowed to incubate 1 h at 4 °C while rocking. After
incubation, the agarose matrix was pelleted at 3000×g for 30 s
and washed 3–4 times in 0.5 ml IP buffer containing protease
inhibitors. After the final wash, the resin was resuspended in
Laemmli buffer lacking β-mercaptoethanol and incubated at 70
°C for 5 min to dissociate bound proteins from the antibody
matrix after which the agarose beads were removed by
centrifugation. The supernatant was transferred to a fresh tube
and adjusted to approximately 0.5% β-mercaptoethanol before
boiling the samples 5 min in preparation for electrophoresis on
SDS-polyacrylamide gels. Subsequent Western blotting was
performed as described above using monoclonal antibodies
12CA5 or 3F10 to detect HA-tagged V protein and monoclonal
H14 (Birrer et al., 1981) to detect MV N protein.
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